Artificial Intelligence-Based Disease Activity Monitoring to Personalized Neovascular Age-Related Macular Degeneration Treatment: A Feasibility Study.

MLA

Mulyukov, Zufar, et al. “Artificial Intelligence-Based Disease Activity Monitoring to Personalized Neovascular Age-Related Macular Degeneration Treatment: A Feasibility Study.” Ophthalmology Science, vol. 4, no. 6, June 2024, p. 100565. EBSCOhost, https://doi.org/10.1016/j.xops.2024.100565.

APA

Mulyukov, Z., Keane, P. A., Sahni, J., Liakopoulos, S., Hatz, K., Wei Ting, D. S., Gallego-Pinazo, R., Aslam, T., Gemmy Cheung, C. M., De Salvo, G., Semoun, O., Somfai, G. M., Stahl, A., Lujan, B. J., & Lorand, D. (2024). Artificial Intelligence-Based Disease Activity Monitoring to Personalized Neovascular Age-Related Macular Degeneration Treatment: A Feasibility Study. Ophthalmology Science, 4(6), 100565. https://doi.org/10.1016/j.xops.2024.100565

Chicago

Mulyukov, Zufar, Pearse A Keane, Jayashree Sahni, Sandra Liakopoulos, Katja Hatz, Daniel Shu Wei Ting, Roberto Gallego-Pinazo, et al. 2024. “Artificial Intelligence-Based Disease Activity Monitoring to Personalized Neovascular Age-Related Macular Degeneration Treatment: A Feasibility Study.” Ophthalmology Science 4 (6): 100565. doi:10.1016/j.xops.2024.100565.